Csilla Özvegy‐Laczka

Author

Institute of Molecular Life Sciences ORCID

Also Known As

C OZVEGYLACZKA, C Özvegy‐Laczka, Csilla Ozvegy-Laczka, Csilla Özvegy-Laczka, Csilla Özvegy-Laczka, Csilla Özvegy‐Laczka, Csilla Özvegy‑laczka, Hegedus, Csilla

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Institute of Molecular Life Sciences HUN-REN Research Centre for Natural Sciences Hungarian Academy of Sciences Semmelweis University Medical University of Vienna

CÖ

About

Csilla Özvegy‐Laczka is an author at Institute of Molecular Life Sciences specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	1.1K
2	Biochemistry	15	15	620
3	Natural Sciences	12	12	559
4	Health Sciences	1	1	71
5	Allergy	1	1	45

Csilla Özvegy‐Laczka

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
High-Affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2 Multidrug Transporter Csilla Özvegy‐Laczka, Tamás Hegedűs, György Várady, Molecular Pharmacology	2004	339
Single nucleotide polymorphisms modify the transporter activity of ABCG2 Kuniaki Morisaki, Robert W. Robey, Csilla Özvegy‐Laczka, Cancer Chemotherapy and Pharmacology Molecular PhysiologyGeneticsHuman PolymorphismBiochemical GeneticsMolecular Biology	2005	235
Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti‐cancer effects and pharmacological properties C. Hegedüs, Csilla Özvegy‐Laczka, Ágota Apáti, British Journal of Pharmacology	2009	226
Multidrug Transporter ABCG2 Prevents Tumor Cell Death Induced by the Epidermal Growth Factor Receptor Inhibitor Iressa (ZD1839, Gefitinib) N. Barry Elkind, Zsófia Szentpétery, Ágota Apáti, Cancer Research	2005	224
Peroxisome Proliferator-activated Receptor γ-regulated ABCG2 Expression Confers Cytoprotection to Human Dendritic Cells István Szatmári, György Vámosi, Péter Brázda, Journal of Biological Chemistry	2006	175
Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter Ágnes Telbisz, Marianna Müller, Csilla Özvegy‐Laczka, Biochimica et Biophysica Acta (BBA) - Biomembranes Molecular PharmacologyMolecular PhysiologyOxysterolBiochemistryMedicine	2007	134
Functional expression and characterization of the human ABCG1 and ABCG4 proteins: indications for heterodimerization Judit Cserepes, Zsófia Szentpétery, L. Serés, Biochemical and Biophysical Research Communications Abcg4 ProteinsHuman Abcg1Protein FunctionMolecular PhysiologyFunctional Genomics	2004	103
Function-dependent Conformational Changes of the ABCG2 Multidrug Transporter Modify Its Interaction with a Monoclonal Antibody on the Cell Surface Csilla Özvegy‐Laczka, György Várady, Gabriella Köblös, Journal of Biological Chemistry	2004	92
Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition Csilla Özvegy‐Laczka, Gabriella Köblös, Balázs Sarkadi, Biochimica et Biophysica Acta (BBA) - Biomembranes Molecular PharmacologySingle Amino AcidBiochemistryMedicineMembrane Transport	2004	80
Inhibitory Effects of Quercetin and Its Main Methyl, Sulfate, and Glucuronic Acid Conjugates on Cytochrome P450 Enzymes, and on OATP, BCRP and MRP2 Transporters Violetta Mohos, Eszter Fliszár-Nyúl, Orsolya Ungvári, Nutrients	2020	80

Page 1